S

Sapienza University of Rome | Hematology Department

Research site

(Unclaimed)

Location

Via Benevento, 6, Rome, Lazio, Italy

Site insights

Top conditions

Top treatments

Vedolizumab

Treprostinil

Methylprednisolone Sodium Succinate

Ribavirin

Omega-3 fatty acids

Aspirin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 23 total trials

A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC)

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to...

Active, not recruiting

Colitis, Ulcerative

Drug: Vedolizumab

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated...

Enrolling

Ulcerative Colitis

Crohn's Disease

Other: No Intervention

Drug: Vedolizumab IV

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients (TripleTRE)

TripleTRE investigates the effect of initial triple combination therapy (oral endothelin receptor antagonist (ERA) + oral phosphodiesterase tyüe-5 in...

Enrolling

Pulmonary Arterial Hypertension

Drug: Generic treprostinil sodium + Standard of Care (Double Oral)

Drug: Standard of Care - Double Oral